Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | | | |
| Selling, general and administrative | | | | | | | | |
| Research and development | | | | | | | | |
| General and administrative | 4.8 | 7.2 | 9.5 | 10.0 | 16.9 | 17.1 | 18.7 | 17.6 |
| EBIT | -11.8 | 4.7 | -30.2 | 54.3 | 2.8 | -83.5 | -18.0 | -57.2 |
| EBIT margin | | | | | | | | |
| Pre-tax income | -14.3 | 27.0 | -37.6 | 54.6 | -15.6 | -88.6 | -22.3 | -59.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -14.3 | 27.0 | -37.6 | 54.6 | -15.6 | -88.6 | -22.3 | -59.5 |
| Net margin | | | | | | | | |
| |
| Diluted EPS | ($0.87) | $1.36 | ($1.81) | $2.64 | ($0.76) | ($4.34) | ($1.09) | ($2.85) |
| Shares outstanding (diluted) | 16.3 | 19.8 | 20.8 | 20.6 | 20.5 | 20.4 | 20.3 | 20.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|